載入...
Optimal two-stage design of single arm Phase II clinical trials based on median event time test
The Phase II clinical trials aim to assess the therapeutic efficacy of a new drug. The therapeutic efficacy has been often quantified by response rate such as overall response rate or survival probability in the Phase II setting. However, there is a strong desire to use survival time, which is the g...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7870013/ https://ncbi.nlm.nih.gov/pubmed/33556130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0246448 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|